Tag: Insulin
IIT Guwahati secures patent for innovative insulin production system
The novel system has potential for insulin production at lower costs and higher yields
Biocon gets six-month extension on insulin supply pact in Malaysia
The company was awarded the insulins supply contract for a three-year period in 2022 through April 2025
Cipla receives approval for distribution & marketing of inhaled insulin in...
As per the company, it is redefining diabetes treatment with an innovative, needle-free alternative that is tailored to meet patient needs in India
Biocon Biologics successfully completes integration of Viatris’ biosimilar business in 31...
In Europe, Biocon Biologics portfolio includes 7 biosimilars: Insulin Aspart and Insulin Glargine, Bevacizumab, Pegfilgrastim, Trastuzumab, Adalimumab, and Etanercept
USV partners Biogenomics to launch INSUQUICK, the first biosimilar Insulin Aspart...
INSUQUICK is 100% Made in India with the potential to improve treatment access for people with diabetes
Insulin pumps market to hit US$ 13.34 billion by 2032: Report
The Asia Pacific market is expected to rise at a high CAGR during the forecast period due to developing healthcare facilities and rising production of advanced insulin pumps
Insulin pumps market to hit US$ 13.34 billion by 2032
The Asia Pacific market is expected to rise at a high CAGR during the forecast period due to developing healthcare facilities
Insulin pumps market to hit US$ 13.34 billion by 2032, predicts report
Demand for patch insulin pumps is predicted to rise at a CAGR of 10% from 2022 to 2032
Diabetes Technology: Improving Care Through Innovation
Research indicates that continuous glucose monitoring has helped people with Type 2 diabetes either on long-acting insulin therapy or non-insulin OAD therapy, significantly reducing their HbA1c levels
Roche launches ACCU-FINE® pen needles for painless insulin delivery
Aims to increase compliance and improve outcomes for People with Diabetes (PwD)